Study of young patients with solid tumors in China
Part of Cancer clinical trials.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed solid tumor cancer (like breast cancer, melanoma, or another type).
- You were 40 years old or younger when first diagnosed.
- Your diagnosis or first treatment at a study hospital happened between January 2010 and May 2026.
- You received at least one standard cancer treatment at that hospital.
- Your medical records, imaging scans (like CT or MRI), and a stored tumor tissue sample are available for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study follows children, teens, and young adults with cancer and people who have completed treatment. It aims to better understand cancer care over time and what affects outcomes, which may help improve future treatment and follow-up.
This research study follows young people (babies through age 21) who have been diagnosed with cancer and are currently receiving treatment or in follow-up care. The study aims to better understand their care experiences and outcomes.
This is an observational study that looks at children and teens (up to age 19) diagnosed with cancer in Shanghai. It aims to understand cancer patterns over time, which can help improve future care.
This trial looks at differences between younger and older breast cancer patients to better understand the disease. If you had breast cancer between the ages of 18 and 75 and were treated in a Chinese hospital from 2000 to 2024, you might be able to help.
This study looks at biological samples from people diagnosed with lung cancer at age 45 or younger. It may help researchers understand how young lung cancers differ, which could guide future treatments.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.